triazoles has been researched along with entinostat in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Brodie, AM; Chumsri, S; Goloubeva, O; Nguyen, N; Sabnis, GJ; Sukumar, S | 1 |
Brodie, AM; Chumsri, S; Howes, T; Sabnis, GJ | 1 |
Brodie, AH; Goloubeva, OG; Kazi, AA; Sabnis, GJ; Shah, P | 1 |
Brodie, A; Chumsri, S; Goloubeva, O; Kazi, A; Rosenblatt, P; Sabnis, GJ; Schech, AJ; Shah, P; Yu, S | 1 |
Babaei, P; Badrikoohi, M; Esmaeili-Bandboni, A | 1 |
5 other study(ies) available for triazoles and entinostat
Article | Year |
---|---|
Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole.
Topics: Animals; Antineoplastic Agents; Aromatase; Benzamides; Blotting, Western; Estrogen Receptor alpha; Female; Humans; Immunohistochemistry; Letrozole; Mice; Mice, Nude; Nitriles; Oligonucleotide Array Sequence Analysis; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Up-Regulation; Xenograft Model Antitumor Assays | 2011 |
Aromatase inhibitors and xenograft studies.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Aromatase Inhibitors; Benzamides; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Letrozole; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Nitriles; Phosphorylation; Pyridines; Receptor, ErbB-2; Receptors, Estrogen; Trastuzumab; Triazoles; Xenograft Model Antitumor Assays | 2011 |
HDAC inhibitor entinostat restores responsiveness of letrozole-resistant MCF-7Ca xenografts to aromatase inhibitors through modulation of Her-2.
Topics: Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Benzamides; Disease Models, Animal; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Letrozole; MAP Kinase Signaling System; MCF-7 Cells; Mice; Nitriles; Pyridines; Receptor, ErbB-2; RNA Stability; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzamides; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Histone Deacetylase Inhibitors; Humans; Letrozole; Mice, Nude; Nitriles; Pyridines; Receptor, ErbB-2; Tretinoin; Triazoles; Xenograft Model Antitumor Assays | 2015 |
Simultaneous administration of bromodomain and histone deacetylase I inhibitors alleviates cognition deficit in Alzheimer's model of rats.
Topics: Alzheimer Disease; Animals; Azepines; Behavior, Animal; Benzamides; CREB-Binding Protein; Disease Models, Animal; Drug Therapy, Combination; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Male; Memory Disorders; Nuclear Proteins; Pyridines; Random Allocation; Rats; Rats, Wistar; Transcription Factors; Triazoles; Tumor Necrosis Factor-alpha | 2022 |